Clazakizumab (Anti-IL-6 / IFNb2), 1mg*5

Clazakizumab (Anti-IL-6 / IFNb2), 1mg*5

Vobarilizumab (Anti-IL-6Ra / CD126), 1mg

Vobarilizumab (Anti-IL-6Ra / CD126), 1mg

Clazakizumab (Anti-IL-6 / IFNb2), 1mg*25

32.845,19 RON
SKU
SKM_A2609_1mg*25

Clazakizumab (Anti-IL-6 / IFNb2) is a monoclonal antibody targeting the IL-6 (interleukin-6). It inhibitsg the cytokine response to SARS-CoV-2 in COVID-19 and can be used for the research of psoriatic arthritis (PsA) and renal antibody-mediated rejection. MW :145.24 KD.

Mai multe informatii
Price 27.601,00 RON (preturile sunt fara TVA)
Description

Clazakizumab (Anti-IL-6 / IFNb2) is a monoclonal antibody targeting the IL-6 (interleukin-6). It inhibitsg the cytokine response to SARS-CoV-2 in COVID-19 and can be used for the research of psoriatic arthritis (PsA) and renal antibody-mediated rejection. MW :145.24 KD.